CGP 52608

CGP 52608
Names
IUPAC name
3-Methyl-1-[(4-oxo-3-prop-2-enyl-1,3-thiazolidin-2-ylidene)amino]thiourea
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1/C8H12N4OS2/c1-3-4-12-6(13)5-15-8(12)11-10-7(14)9-2/h3H,1,4-5H2,2H3,(H2,9,10,14)/b11-8-
    Key: DDYJDIHOSRTMSE-FLIBITNWBI
  • S=C(N\N=C1/SCC(=O)N1C\C=C)NC
Properties
C8H12N4OS2
Molar mass 244.33 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

CGP 52608 is a selective ligand of the RAR-related orphan receptor alpha. It has been used as a biochemical tool to investigate nuclear and membrane signaling of melatonin. CGP 52608 has also been reported to possess antiarthritic activity. The pharmaceutical company Novartis brought it to clinical trials for rheumatoid arthritis, but development was discontinued in 2006.

CGP 52608 contains a thiazolinidinedione group.